JPWO2021209759A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021209759A5 JPWO2021209759A5 JP2022562606A JP2022562606A JPWO2021209759A5 JP WO2021209759 A5 JPWO2021209759 A5 JP WO2021209759A5 JP 2022562606 A JP2022562606 A JP 2022562606A JP 2022562606 A JP2022562606 A JP 2022562606A JP WO2021209759 A5 JPWO2021209759 A5 JP WO2021209759A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- population
- modified
- cell
- akt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2005617.2 | 2020-04-17 | ||
| GBGB2005617.2A GB202005617D0 (en) | 2020-04-17 | 2020-04-17 | Improved t cell manufacturing process |
| PCT/GB2021/050909 WO2021209759A1 (en) | 2020-04-17 | 2021-04-16 | Improved t cell manufacturing process |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023521875A JP2023521875A (ja) | 2023-05-25 |
| JPWO2021209759A5 true JPWO2021209759A5 (https=) | 2024-04-25 |
| JP2023521875A5 JP2023521875A5 (https=) | 2024-04-25 |
| JP7760524B2 JP7760524B2 (ja) | 2025-10-27 |
Family
ID=70859978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562606A Active JP7760524B2 (ja) | 2020-04-17 | 2021-04-16 | 改善されたｔ細胞製造プロセス |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230133064A1 (https=) |
| EP (1) | EP4136216A1 (https=) |
| JP (1) | JP7760524B2 (https=) |
| CN (1) | CN115397975A (https=) |
| CA (1) | CA3175266A1 (https=) |
| GB (1) | GB202005617D0 (https=) |
| WO (1) | WO2021209759A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116970059A (zh) | 2016-12-22 | 2023-10-31 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| US11851471B2 (en) | 2017-01-09 | 2023-12-26 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| IL269000B2 (en) | 2017-03-15 | 2024-06-01 | Cue Biopharma Inc | Methods for modulating an immune response |
| TW202208395A (zh) | 2020-05-12 | 2022-03-01 | 美商信號生物製藥公司 | 多聚體ｔ細胞調節多肽及其使用方法 |
| EP4211149A4 (en) | 2020-09-09 | 2024-10-09 | Cue Biopharma, Inc. | MULTIMERIC POLYPEPTIDES MODULATING MHC CLASS II T CELLS FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF |
| CN116496283B (zh) * | 2022-01-18 | 2024-04-19 | 中国药科大学 | 五氮杂苊类化合物、制备方法、药物组合物和应用 |
| JP2025515473A (ja) * | 2022-04-28 | 2025-05-15 | キュー バイオファーマ， インコーポレイテッド | 改変された細胞傷害性ｔ細胞およびその使用方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3151672T1 (sl) * | 2014-06-06 | 2021-03-31 | Bluebird Bio, Inc. | Izboljšani T-celični sestavki |
| EP3364969A4 (en) * | 2015-10-20 | 2019-07-10 | Kite Pharma, Inc. | METHOD FOR THE PRODUCTION OF T CELLS FOR T CELL THERAPY |
| WO2017070042A1 (en) * | 2015-10-20 | 2017-04-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of producing t cell populations using akt inhibitors |
| US20180320133A1 (en) * | 2015-11-05 | 2018-11-08 | City Of Hope | Methods for preparing cells for adoptive t cell therapy |
-
2020
- 2020-04-17 GB GBGB2005617.2A patent/GB202005617D0/en not_active Ceased
-
2021
- 2021-04-16 WO PCT/GB2021/050909 patent/WO2021209759A1/en not_active Ceased
- 2021-04-16 EP EP21721165.5A patent/EP4136216A1/en active Pending
- 2021-04-16 JP JP2022562606A patent/JP7760524B2/ja active Active
- 2021-04-16 CA CA3175266A patent/CA3175266A1/en active Pending
- 2021-04-16 CN CN202180029152.2A patent/CN115397975A/zh active Pending
-
2022
- 2022-10-14 US US18/046,874 patent/US20230133064A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230092130A1 (en) | Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof | |
| US20210187028A1 (en) | Polyclonal gamma delta t cells for immunotherapy | |
| JP2025011150A (ja) | ガンマ－デルタｔ細胞およびナチュラルキラー細胞の治療的調製物ならびに製造および使用する方法 | |
| TWI719942B (zh) | 使用ｃｄ３３嵌合抗原受體治療癌症 | |
| ES3023783T3 (en) | Engineered gamma delta t-cells | |
| US20220411754A1 (en) | Methods and compositions for enhanced expansion and cytotoxicity of natural killer cells | |
| US20210054346A1 (en) | Selection methods for genetically-modified t cells | |
| TW202134285A (zh) | Ｃｄ１９和ｃｄ２２嵌合抗原受體及其用途 | |
| CA3118493A1 (en) | Expansion of tils utilizing akt pathway inhibitors | |
| JP2020513243A (ja) | 養子免疫療法における免疫細胞調節のための組成物および方法 | |
| CA3123392A1 (en) | Methods of expanding tumor infiltrating lymphocytes using engineered cytokine receptor pairs and uses thereof | |
| JP2023509708A (ja) | 抗ｔｃｒ抗体分子およびその使用 | |
| KR20180096707A (ko) | 입양 면역요법에서 면역 세포 조절을 위한 조성물 및 방법 | |
| US20130101567A1 (en) | Methods to Expand a T Regulatory Cell Master Cell Bank | |
| JPWO2021209759A5 (https=) | ||
| US20220175834A1 (en) | Methods for culturing immune cells | |
| US20210290672A1 (en) | Regulation of tumor-associated t cells | |
| IL324321A (en) | Multi-receptor natural killer cells | |
| JP2025063190A (ja) | リンホトキシンアルファ遮断剤によりターゲットされた制御性ｔ細胞及びその使用 | |
| Kawai et al. | Feeder-free generation of CD4 single-positive helper T cells from human iPSCs via stage-specific modulation of Notch and TCR Signaling | |
| JPWO2022216837A5 (https=) | ||
| Maia et al. | Cytokine-Induced Memory-Like NK Cells for Improved Cancer Immunotherapy | |
| JPWO2023081317A5 (https=) | ||
| ES2973543T3 (es) | Cultivos de células T CD28, composiciones y métodos de uso de los mismos | |
| RU2839702C2 (ru) | Способы и композиции для усиления размножения и цитотоксичности клеток, являющихся натуральными киллерами |